WebDisclosure WebDisclosure
Basculer en Français
10843 Companies
235452 Keywords
164391 Articles
126145 Press releases
Headlines Articles Press releases Wilmington Eye Remove
  1. Home
  2. Companies
  3. Wilmington Eye
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 05/28/2024 at 22:35, 2 years 2 months ago

    Wilmington Eye Now Offering iDose(R) TR as a New Treatment Option to Reduce Eye Pressure in Patients With Ocular Hypertension and Open-Angle Glaucoma

    Medical Innovation Ocular Hypertension Wilmington Eye IDose TR Glaucoma Treatment
  • BRIEF

    published on 05/28/2024 at 22:35, 2 years 2 months ago

    Wilmington Eye propose désormais iDose(R) TR comme nouvelle option de traitement pour réduire la pression oculaire chez les patients souffrant d'hypertension oculaire et de glaucome à angle ouvert

    Innovation Médicale IDose TR Oeil De Wilmington Traitement Du Glaucome Hypertension Oculaire
  • PRESS RELEASE

    published on 05/28/2024 at 22:30, 2 years 2 months ago

    Wilmington Eye Now Offering iDose(R) TR as a New Treatment Option to Reduce Eye Pressure in Patients With Ocular Hypertension and Open-Angle Glaucoma

    Wilmington Eye introduces iDose TR for long-term control of elevated eye pressure in glaucoma patients. iDose TR is an FDA approved treatment providing continuous drug therapy inside the eye
    FDA Approved Wilmington Eye IDose TR Glaucoma Treatment Eye Pressure Control
    Logo of Wilmington Eye
Accesswire
  • Published on 08/17/2026 at 15:00, 3 hours 15 minutes ago

    Norsemont Appoints Ariel Tepperman to Its Board

  • Published on 08/17/2026 at 14:30, 3 hours 45 minutes ago

    Alset AI Completes Sale of 9.9% Interest in Lyken AI Computing to FingerMotion

  • Published on 08/17/2026 at 14:00, 4 hours 15 minutes ago

    FaZe Esports, a GameSquare Company, Wins Rainbow Six Championship at 2026 Esports World Cup

  • Published on 08/17/2026 at 14:00, 4 hours 15 minutes ago

    Orogen Royalties and Aurum Discovery form Generative Alliance in Norway

  • Published on 08/17/2026 at 13:00, 5 hours 15 minutes ago

    Eagle Plains Samples up to 269g/t Au at the Pine Channel Gold Project, Saskatchewan

View all ACCESSWIRE
EQS Group
  • Published on 08/17/2026 at 17:50, 25 minutes ago

    EvoNext Holdings SA confirms advanced discussions on a reverse merger with Ascend Sport Technology AG

  • Published on 08/17/2026 at 17:47, 28 minutes ago

    Key Figures 15.08.2026

  • Published on 08/17/2026 at 17:45, 30 minutes ago

    Press release: Information on Leonteq's shareholder base

  • Published on 08/17/2026 at 17:40, 35 minutes ago

    VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social au 31.07.26.

  • Published on 08/17/2026 at 17:32, 42 minutes ago

    SCHOTT Pharma advances climate action with updated science-based climate targets

View all EQS
Les Echos
  • Published on 08/17/2026 at 17:45, 30 minutes ago

    Weekly share buyback

  • Published on 08/17/2026 at 17:45, 30 minutes ago

    Déclaration hebdomadaire de rachat d'actions

  • Published on 08/17/2026 at 17:40, 35 minutes ago

    Infotel : Déclaration des transactions sur actions propres réalisées du 10 au 14 août 2026 dans le cadre du programme de rachat d’actions.

  • Published on 08/17/2026 at 14:19, 3 hours 56 minutes ago

    Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

  • Published on 08/17/2026 at 09:59, 8 hours 16 minutes ago

    260817 BENETEAU Transaction sur actions propres

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy